Biomat USA
- Company typePrivate
- Founded1986
- HeadquartersLos Angeles, United States
- Headcount251–500
- GTM typeB2C
- OfferingServices
Biomat USA firmographics
Firmographics- Name
- Biomat USA
- Legal name
- Biomat USA, Inc.
- Website
- https://grifolsplasma.com
- Company type
- Private
- Founded year
- 1986
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
Biomat USA industry classification
Industry- Product category
- Plasma Collection Services
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH)
- akta.pro secondary industries
- Blood, Organ & Tissue Donation Organizations (BPAGACAJ), Plasma Fractionation & Purification Manufacturing (HLAIAHAI)
Keywords
Where Biomat USA is headquartered
LocationHeadquarters
- HQ city
- Los Angeles
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Biomat USA business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain
Revenue model
- Plasma Collection Services: Biomat USA operates plasma donation centers that collect plasma from donors. The collected plasma is used by Grifols to manufacture plasma-derived medicines. Revenue is generated through the value of plasma collected and processed for biopharmaceutical manufacturing.
- Plasma-Derived Medicines Manufacturing: Grifols manufactures plasma medicines including treatments for hemophilia, Alpha-1 Antitrypsin Deficiency, primary immunodeficiency diseases, and other conditions. The company operates manufacturing facilities and sells finished pharmaceutical products globally.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Usage-based | Pay-as-you-go | Standard plasma donation compensation |
| Transaction based/ take rate | Pay-as-you-go | Refer a Friend Program |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Biomat USA product offering
Product offeringCore offering
Biomat USA operates a network of plasma donation centers in the United States as a subsidiary of Grifols. Healthy adult donors visit these centers to donate plasma through plasmapheresis, a process that separates plasma from other blood components and returns the cells to the donor. Donors are compensated via prepaid debit card, and the collected plasma is supplied to Grifols for manufacturing plasma-derived medicines used to treat hemophilia, Alpha-1 Antitrypsin Deficiency, primary immunodeficiency, and other conditions.
Product overview
Biomat USA, a subsidiary of Grifols, operates the Grifols Plasma network of plasma donation centers — the world's most diversified plasma collection network with over 400 centers. The core offering centers on plasma collection services, supplemented by the DonorHub™ digital platform for donor management. Specialty Plasma Programs offer enhanced compensation for donors with specific antibodies. The Refer a Friend Program drives donor acquisition through incentives. Grifols Plasma Promo Alerts enables SMS-based donor communication. All donors receive compensation via a pre-paid debit card system.
Differentiator
Problem solved
Functional benefit
Products and services
- Grifols Plasma Donation Centers Physical plasma donation centers where healthy adult donors (18-69 years old, at least 110 lbs) can donate plasma via plasmapheresis. The collected plasma is supplied to Grifols for manufacturing plasma-derived medicines. Donors are compensated via prepaid debit card. The network is part of Grifols' 400+ center global collection network.
- DonorHub Mobile and web application that allows plasma donors to manage appointments, check in, view estimated wait times, track donation history and compensation, and access referral codes for the Refer a Friend program. Available on iOS and Android.
- Specialty Plasma Programs Targeted plasma donation programs for donors with specific antibodies, including Anti-Hepatitis B, Anti-D (Rho(D)), Anti-Tetanus, Anti-Rabies, Anti-RSV, and Male AB Programs. Donors receive additional compensation and supply plasma for targeted immunoglobulin products.
- Refer a Friend Program Referral program allowing existing donors to invite friends to become plasma donors. Referrers receive a $100 USD bonus per valid referral once the referred friend registers with their code via DonorHub and completes two donations.
Quantifiable outcome
- 1,200 milliliters of plasma collected per donation
- +5 more outcomes
Companies that use Biomat USA
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles2 records
Biomat USA technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Biomat USA partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered minor and core.
- USO (United Service Organizations)minorGrifols is a long-time partner of USO, supporting men and women serving in the U.S. military and their families. Many Grifols employees and donors are active military or veterans.
- Habitat for HumanityminorGrifols collaborates with Habitat for Humanity locally and nationally. Employees have participated in multiple house and playground builds. The J.A. Grifols Foundation has supported Habitat affiliates with community improvement grants.
- Feeding AmericaminorGrifols supports Feeding America nationally to fight hunger. Through the Box Out Hunger food drive, Grifols has donated close to 2.7 million pounds of food to local communities over 5 years. Food bank drop-off locations are created at Grifols donor centers.
- Plasma Protein Therapeutics Association (PPTA)corePPTA is the industry association for plasma protein therapeutics. Grifols collaborates through PPTA's Pathogen Safety Steering Committee. PPTA launched International Plasma Awareness Week (IPAW) in 2013.
- National Organization for Rare Disorders (NORD)minorThe J.A. Grifols Foundation and NORD established the Plasma Donor Emergency Relief Program (PDER) to provide non-medical financial assistance to eligible plasma donors. The program is currently being piloted at 6 U.S. Grifols plasma centers.
- J.A. Grifols Lucas FoundationcoreThe Jose Antonio Grifols Lucas Foundation provides support to communities where plasma donors are valued. It awards quarterly community enhancement grants for civic, social, or educational programs addressing community needs where Grifols plasma centers exist.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Biomat USA competitors and assessment
Company assessmentDirect peers
- Kedrion Biopharma: Global plasma fractionator with U.S. plasma collection operations, collecting source plasma for its own therapies; overlaps with Biomat USA on both the collection and fractionation side of the value chain.
- CSL Plasma: U.S. plasma collection subsidiary of CSL Behring, operating a large network of paid plasma donation centers; the closest direct competitor to Biomat USA in the U.S. source-plasma market.
- Octapharma Plasma: U.S. plasma collection business of Octapharma AG, running a sizable chain of paid plasma donation centers; competes head-to-head with Biomat USA for donors in overlapping U.S. geographies.
- BioLife Plasma Services: Plasma collection subsidiary of Takeda, operating hundreds of U.S. paid plasma donation centers; directly comparable to Biomat USA in donor compensation, center model, and downstream fractionation use.
- BPL Plasma: U.S. plasma collection arm of Bio Products Laboratory, operating a network of paid plasma donation centers; directly competes with Biomat USA for U.S. source plasma.
Emerging players
- ADMA Biologics: U.S. specialty immune globulin manufacturer building out its own plasma collection footprint (ADMA BioCenters); partial overlap with Biomat USA — a smaller but growing collector in the same value chain.
Regional players
- American Red Cross: Large U.S. nonprofit blood and plasma collector; comparable activities in source-material collection but operates on a volunteer, non-compensated model and therefore does not compete directly for paid donors.
- Sanquin Plasma Products: Dutch nonprofit blood and plasma collector with growing paid plasma programs in Europe and the U.S.; comparable collection activity to Biomat USA but with a primary European footprint and non-compensated legacy model.
Broad incumbents
- Takeda Pharmaceutical Company: Parent of BioLife Plasma Services; a global biopharmaceutical major whose plasma-derived therapy franchise is directly dependent on the same U.S. source plasma supply chain that Biomat USA feeds into Grifols.
- CSL Behring: Parent of CSL Plasma and one of the world's largest plasma fractionators; competes with Grifols (and therefore Biomat USA) end-to-end across plasma collection and plasma-derived therapeutics.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Biomat USA financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biomat USA leadership team
Management profileNumber of profiles
Profiles1 record
Biomat USA funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biomat USA M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biomat USA
What does Biomat USA do?
Biomat USA operates a network of plasma donation centers in the United States as a subsidiary of Grifols. Healthy adult donors visit these centers to donate plasma through plasmapheresis, a process that separates plasma from other blood components and returns the cells to the donor. Donors are compensated via prepaid debit card, and the collected plasma is supplied to Grifols for manufacturing plasma-derived medicines used to treat hemophilia, Alpha-1 Antitrypsin Deficiency, primary immunodeficiency, and other conditions.
Is Biomat USA a public or private company?
Biomat USA is a private company. It is classified as corporate owned and is currently operating.
When was Biomat USA founded?
Biomat USA was founded in 1986. It employs 251 to 500 people.
Where is Biomat USA based?
Biomat USA is headquartered in Los Angeles, United States, in the North America region.
How does Biomat USA make money?
Two revenue lines are on record. Plasma Collection Services are the primary driver. The others are plasma-Derived Medicines Manufacturing.
Who are Biomat USA's main competitors?
Direct peers on record are Kedrion Biopharma, CSL Plasma, Octapharma Plasma, BioLife Plasma Services and BPL Plasma. ADMA Biologics is listed as an emerging player. Regional players are American Red Cross and Sanquin Plasma Products. Broad incumbents are Takeda Pharmaceutical Company and CSL Behring.
Does Biomat USA have an API?
No public API is recorded for Biomat USA.
What industry is Biomat USA in?
Biomat USA's product category is Plasma Collection Services. Its primary akta.pro industry code is HLAIAHAH, Plasma Collection & Donor Services (Plasmapheresis Centers), with a secondary code of BPAGACAJ, Blood, Organ & Tissue Donation Organizations. Its NAICS code is 621991 and its SIC code is 2836.